07/08/2026
Exciting!
A phase 1b/2a clinical trial testing neural stem cells for Huntington's disease has reached a major milestone. After more than 12 years of research and eight years of planning, the first participant received the world's first neural stem cell intervention for HD at UCI Health in May. So far, no adverse effects have been reported, and a second participant is scheduled to receive treatment in July. The trial marks an important step in exploring whether neural stem cells could help treat Huntington's disease.
Photo from UCI Health.
Learn more here: https://en.hdbuzz.net/first-participant-dosed-in-pioneering-neural-stem-cell-trial-for-huntingtons-disease/